comparemela.com

Latest Breaking News On - Theramex viatris - Page 1 : comparemela.com

Pharma deal could reduce choice and lead to higher prices for HRT treatments | Competition & Markets Authority

Following its Phase 1 investigation, the CMA has found that Theramex s proposed purchase of Femoston and Duphaston could reduce competition and choice for hormone replacement therapy treatments.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.